CD138 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

199 results for “CD138”

Trials

View all 112 →

Not yet recruiting

Hysteroscopy and CD138+ Plasma Cell Density in Chronic Endometritis

100 participants · First posted Jul 29, 2026

The Relationship Between CD138 Count of Endometrium and Reproductive Outcome

148 participants · First posted Sep 28, 2018

Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells

30 participants · First posted Dec 19, 2018

Drugs

View all 72 →

Investigational

PVX-410 component CD138 260-268(GLVGLIFAV)

Anti-CD138-interferon alpha2 fusion protein (Qwixel Therapeutics)

Anti-CD138 CAR-T cell therapy (Yake Biotechnology)

News

View all 15 →

Nammi Therapeutics Initiates Phase I Trial of QXL138AM for Advanced Cancers and Multiple Myeloma

Nammi Therapeutics Initiates Phase 1 Trial of QXL138AM in Advanced Solid Tumors and Multiple Myeloma

PYGO2 Identified as Key Driver of 1q21+ Multiple Myeloma Progression and Potential Therapeutic Target

Page 1 of 20